Press Releases

GlobeNewswire, Inc.

VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its...

GlobeNewswire, Inc.

Austin, TX, USA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “AI SDR Market Size, Trends and Insights By Offering (Meeting Booking, AI SDR Generators, AI Script, Enrichment, Email...

GlobeNewswire, Inc.

RENO, Nev., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Biotech Insider News Commentary - For thirty years the answer to lost facial and body volume has been to put something back in. Fillers occupy space, implants occupy space, and the industry built...

GlobeNewswire, Inc.

TORONTO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- OMERS generated a net investment return of 4.8%, a gain of $6.9 billion, for the period of January 1 to June 30, 2026. Net assets as at June 30, 2026 totalled $151.6 billion. “OMERS had a pleasing start...

GlobeNewswire, Inc.

Austin, TX, USA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Direct Reduced Iron Market Size, Trends and Insights By Product Type (Hot Briquetted Iron, Cold Direct Reduced Iron), By...

GlobeNewswire, Inc.

Q2 2026 revenue of $29.1 million; GAAP basic EPS: $(0.12) Full year 2026 revenue guidance of $100.5 to $111.0 million affirmed NDA for F351 (hydronidone) for CHB-induced liver fibrosis accepted by China’s CDE in May 2026 SAN DIEGO, Aug. 07, 2026...

EIN Presswire

AI Governance World has added top AI Governance experts and authors to its slate of speakers, including leaders from OpenAI, SAIC, AXA, and Pathfinder.ai. LAS VEGAS, NV, UNITED STATES, August 11, 2026 /⁨EINPresswire.com⁩/ -- The AI Governance...

GlobeNewswire, Inc.

New York, NY, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that Timothy J. Davies joined the firm as Managing Director. “Timothy’s...

GlobeNewswire, Inc.

MONTRÉAL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the first quarter of fiscal 2027, which ended on June 30, 2026. All amounts in this news release are in...

GlobeNewswire, Inc.

LONG BEACH, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2026...

GlobeNewswire, Inc.

– Operating expenses decline 16%, helping drive a 39% improvement in net loss – – Approximately $3.1 million of TULSA revenue recognition shifts into early Q3 due to shipment timing – – Strong clinical, commercial and reimbursement momentum...

GlobeNewswire, Inc.

Steady revenue growth and adjusted EBITDA margin* expansion Three consecutive quarters of double-digit software Annual Recurring Revenue* (“ARR”) growth TORONTO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus Group”, “Altus” or “the...

GlobeNewswire, Inc.

Company pivot to neuro-ophthalmology continues with Privosegtor positioned as lead late-stage asset through the registrational PIONEER program with expansion potential in acute multiple sclerosis (MS) relapses following positive FDA pre-IND...

GlobeNewswire, Inc.

- Duchenne (SGT-003): SGT-003 has been generally well tolerated in the Phase 1/2 INSPIRE DUCHENNE clinical trial, with 53 participants dosed as of August 4, 2026 - - Solid expects to meet with the FDA in late Q4 2026 to discuss the SGT-003 data...

GlobeNewswire, Inc.

Advancing the Alector Brain Carrier (ABC) blood-brain barrier platform across antibodies, enzymes, and siRNA, with AL137 advancing as Alector’s lead ABC-enabled anti-amyloid beta (Aβ) antibody program for Alzheimer’s disease (AD). Continued...

GlobeNewswire, Inc.

DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- (https://247mnn.com/) – ClearOne (NASDAQ: CLRO), NeOnc Technologies (NASDAQ: NTHI), Iovance Biotherapeutics (NASDAQ:IOVA), and Ensysce Biosciences (NASDAQ:ENSC) are covered in today’s roundup.

GlobeNewswire, Inc.

New York, NY , Aug. 06, 2026 (GLOBE NEWSWIRE) -- Executive Summary AusWin has unveiled its innovative interactive digital games platform, expanding entertainment options for players throughout Australia.

GlobeNewswire, Inc.

Immunocore reports second quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $115.9 million in Q2 2026, growing by 18% year-over-year Enrollment in Phase 3 TEBE-AM trial for previously treated...

EIN Presswire

AI in Fintech Market is growing with AI-powered fraud detection, risk analysis, customer service, personalized banking, and automation.

GlobeNewswire, Inc.

NEW YORK and MELBOURNE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative combination therapies and...